Nancy is an internationally recognized thought leader and C level executive in translation and commercialization of cell-based therapy and regenerative medicine.She was the principal scientist responsible for the first US approved living cell therapy, a bioengineered living skin construct (Apligraf®, Organogenesis Inc.), which remains the most advanced product for the treatment of chronic wounds.She rose to prominence in the tissue engineering field during her fifteen years at Organogenesis Inc. ultimately becoming its Senior Vice President and CSO.

As Verik's President and CSO, Nancy contributes leadership, vision and strategy and is active in target discovery and technology development.

Nancy received her degree in cell and developmental biology and anatomy from Georgetown University School of Medicine and trained in epithelial biology and carcinoma as a Harvard postdoc.